Study Associates Chronic Dysglycemia (HbA1c ≥ 5.8%) with Inflammation, Endothelial Dysfunction, and Higher Cardiovascular Event Rates post STEMI

Many prevention specialists believe that we are not diagnosing diabetes early enough if we wait for hemoglobin A1c (HbA1c) levels to reach ≥ 6.5%.  Filepe Moura and colleagues sought to find out if there was a relationship between HbA1c  levels in non-diabetic ST-elevation myocardial infarction (STEMI) patients and recurrent cardiac events.  Read more Study Associates Chronic Dysglycemia (HbA1c ≥ 5.8%) with Inflammation, Endothelial Dysfunction, and Higher Cardiovascular Event Rates post STEMI

New Evidence about the Role of Inflammation in Promoting Coronary Atherosclerosis

A recent study published in the journal Atherosclerosis involved investigating epicardial adipose tissue (EAT) pathology, as determined by neoangiogenesis and inflammation, and atherosclerosis in the coronary arteries as determined by computed tomography (CT) imaging. Read more New Evidence about the Role of Inflammation in Promoting Coronary Atherosclerosis